Ocular Inflammation Induced by Immune Checkpoint Inhibitors

Ocular immunotherapy-related adverse events (IRAEs), although rare, can be sight-threatening. Our objective was to analyze ocular IRAEs diagnosed in France from the marketing of immune checkpoint inhibitors (ICPIs) until June 2021 and to review the literature. We collected the cases of 28 patients (...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudot, Florence, Sève, Pascal, Rousseau, Antoine, Maria, Alexandre Thibault Jacques, Fournie, Pierre, Lozach, Pierre, Keraen, Jeremy, Servant, Marion, Muller, Romain, Gramont, Baptiste, Touhami, Sara, Mahmoud, Habeeb, Quintart, Pierre-Antoine, Dalle, Stéphane, Lambotte, Olivier, Kodjikian, Laurent, Jamilloux, Yvan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456546/
https://www.ncbi.nlm.nih.gov/pubmed/36078923
http://dx.doi.org/10.3390/jcm11174993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456546/
https://www.ncbi.nlm.nih.gov/pubmed/36078923
http://dx.doi.org/10.3390/jcm11174993

Ejemplares similares